Adenosine A2A receptors permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: A possible key mechanism in NMDA receptor modulation

Journal of Neurochemistry

Volumn 135, Issue 4, 2015, Pages 714-726

  Sarantis, Konstantinos ^a   Tsiamaki, Eirini ^a   Kouvaros, Stylianos ^a   Papatheodoropoulos, Costas ^a   Angelatou, Fevronia ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

adenosineA2AR; hippocampus; mGluR5; NR2B; phosphorylation; Src kinases

Indexed keywords

ADENOSINE A2A RECEPTOR; METABOTROPIC RECEPTOR 5; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN TYROSINE KINASE; TYROSINE; ADENOSINE A2 RECEPTOR; AMINO ACID RECEPTOR AFFECTING AGENT; GRM5 PROTEIN, RAT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR2B NMDA RECEPTOR; PURINERGIC RECEPTOR AFFECTING AGENT;

ADULT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVATION; EVOKED RESPONSE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; MALE; NERVE EXCITABILITY; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RAT; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; GENETICS; IN VITRO STUDY; METABOLISM; NONPARAMETRIC TEST; PATCH CLAMP TECHNIQUE; PHOSPHORYLATION; PHYSIOLOGY; WISTAR RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGENTS; HIPPOCAMPUS; IN VITRO TECHNIQUES; MALE; PATCH-CLAMP TECHNIQUES; PHOSPHORYLATION; PURINERGIC AGENTS; RATS; RATS, WISTAR; RECEPTOR, METABOTROPIC GLUTAMATE 5; RECEPTORS, ADENOSINE A2; RECEPTORS, N-METHYL-D-ASPARTATE; STATISTICS, NONPARAMETRIC; TYROSINE;

EID: 84946128465     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13291     Document Type: Article

References (62)

1. Alagarsamy S., Marino M. J., Rouse S. T., Gereau R. W. T., Heinemann S. F., and, Conn P. J., (1999) Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nat. Neurosci. 2, 234-240.
2. Anwyl R., (1999) Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res. Brain Res. Rev. 29, 83-120.
3. Attucci S., Carla V., Mannaioni G., and, Moroni F., (2001) Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges. Br. J. Pharmacol. 132, 799-806.
4. Ayala J. E., Chen Y., Banko J. L., et al,. (2009) mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology, 34, 2057-2071.
5. Baude A., Nusser Z., Roberts J. D., Mulvihill E., McIlhinney R. A., and, Somogyi P., (1993) The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 11, 771-787.
6. Bortolotto Z. A., Fitzjohn S. M., and, Collingridge G. L., (1999) Roles of metabotropic glutamate receptors in LTP and LTD in the hippocampus. Curr. Opin. Neurobiol. 9, 299-304.
7. Brooks-Kayal A. R., Shumate M. D., Jin H., Rikhter T. Y., Kelly M. E., and, Coulter D. A., (2001) gamma-Aminobutyric acid(A) receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development. J. Neurochem. 77, 1266-1278.
8. Chen B. S., and, Roche K. W., (2007) Regulation of NMDA receptors by phosphorylation. Neuropharmacology 53, 362-368.
9. Collett V. J., and, Collingridge G. L., (2004) Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells. Br. J. Pharmacol. 142, 991-1001.
10. Conn P. J., and, Pin J. P., (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37, 205-237.
11. Cunha R. A., Constantino M. D., and, Ribeiro J. A., (1997) ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Br. J. Pharmacol. 122, 1279-1284.
12. Dell'anno M. T., Pallottino S., and, Fisone G., (2013) mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons. Neuropharmacology, 66, 179-186.
13. Doherty A. J., Palmer M. J., Henley J. M., Collingridge G. L., and, Jane D. E., (1997) (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology 36, 265-267.
14. Domenici M. R., Pepponi R., Martire A., Tebano M. T., Potenza R. L., and, Popoli P., (2004) Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum. J. Neurochem. 90, 1276-1279.
15. Eichenbaum H., (2004) Hippocampus: cognitive processes and neural representations that underlie declarative memory. Neuron 44, 109-120.
16. Ferraguti F., and, Shigemoto R., (2006) Metabotropic glutamate receptors. Cell Tissue Res. 326, 483-504.
17. Ferre S., Karcz-Kubicha M., Hope B. T., et al,. (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc. Natl Acad. Sci. USA 99, 11940-11945.
18. Forsythe I. D., and, Westbrook G. L., (1988) Slow excitatory postsynaptic currents mediated by N-methyl-D-aspartate receptors on cultured mouse central neurones. J. Physiol. 396, 515-533.
19. Goh J. J., and, Manahan-Vaughan D., (2013) Endogenous hippocampal LTD that is enabled by spatial object recognition requires activation of NMDA receptors and the metabotropic glutamate receptor, mGlu5. Hippocampus 23, 129-138.
20. Gray L., van den Buuse M., Scarr E., Dean B., and, Hannan A. J., (2009) Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation. Int. J. Neuropsychopharmacol. 12, 45-60.
21. Hanke J. H., Gardner J. P., Dow R. L., Changelian P. S., Brissette W. H., Weringer E. J., Pollok B. A., and, Connelly P. A., (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271, 695-701.
22. Homayoun H., and, Moghaddam B., (2010) Group 5 metabotropic glutamate receptors: role in modulating cortical activity and relevance to cognition. Eur. J. Pharmacol. 639, 33-39.
23. Homayoun H., Stefani M. R., Adams B. W., Tamagan G. D., and, Moghaddam B., (2004) Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release. Neuropsychopharmacology, 29, 1259-1269.
24. Jia Z., Lu Y., Henderson J., Taverna F., Romano C., Abramow-Newerly W., Wojtowicz J. M., and, Roder J., (1998) Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learn. Mem. 5, 331-343.
25. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., and, Watanabe M., (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89, 309-380.
26. Kotecha S. A., Jackson M. F., Al-Mahrouki A., Roder J. C., Orser B. A., and, MacDonald J. F., (2003) Co-stimulation of mGluR5 and N-methyl-D-aspartate receptors is required for potentiation of excitatory synaptic transmission in hippocampal neurons. J. Biol. Chem. 278, 27742-27749.
27. Lan J. Y., Skeberdis V. A., Jover T., Zheng X., Bennett M. V., and, Zukin R. S., (2001) Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking. J. Neurosci. 21, 6058-6068.
28. Lau C. G., and, Zukin R. S., (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 8, 413-426.
29. Lavezzari G., McCallum J., Lee R., and, Roche K. W., (2003) Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression. Neuropharmacology 45, 729-737.
30. Lecourtier L., Homayoun H., Tamagnan G., and, Moghaddam B., (2007) Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biol. Psychiatry 62, 739-746.
31. Lee H. K., (2006) Synaptic plasticity and phosphorylation. Pharmacol. Ther. 112, 810-832.
32. Lev S., Moreno H., Martinez R., Canoll P., Peles E., Musacchio J. M., Plowman G. D., Rudy B., and, Schlessinger J., (1995) Protein tyrosine kinase PYK2 involved in Ca(2 +)-induced regulation of ion channel and MAP kinase functions. Nature 376, 737-745.
33. Lu Y. M., Jia Z., Janus C., Henderson J. T., Gerlai R., Wojtowicz J. M., and, Roder J. C., (1997) Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J. Neurosci. 17, 5196-5205.
34. Lujan R., Nusser Z., Roberts J. D., Shigemoto R., and, Somogyi P., (1996) Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neuorsci. 8, 1488-1500.
35. Manahan-Vaughan D., and, Braunewell K. H., (2005) The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cereb. Cortex 15, 1703-1713.
36. Mannaioni G., Marino M. J., Valenti O., Traynelis S. F., and, Conn P. J., (2001) Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J. Neurosci. 21, 5925-5934.
37. Mao L., and, Wang J. Q., (2002a) Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors. Mol. Pharmacol. 62, 473-484.
38. Mao L., and, Wang J. Q., (2002b) Interactions between ionotropic and metabotropic glutamate receptors regulate cAMP response element-binding protein phosphorylation in cultured striatal neurons. Neuroscience 115, 395-402.
39. Nakazawa T., Komai S., Tezuka T., Hisatsune C., Umemori H., Semba K., Mishina M., Manabe T., and, Yamamoto T., (2001) Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 276, 693-699.
40. Nakazawa T., Komai S., Watabe A. M., et al,. (2006) NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. EMBO J. 25, 2867-2877.
41. Nicoletti F., Bockaert J., Collingridge G. L., Conn P. J., Ferraguti F., Schoepp D. D., Wroblewski J. T., and, Pin J. P., (2011) Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 60, 1017-1041.
42. Papatheodoropoulos C., Moschovos C., and, Kostopoulos G., (2005) Greater contribution of N-methyl-D-aspartic acid receptors in ventral compared to dorsal hippocampal slices in the expression and long-term maintenance of epileptiform activity. Neuroscience 135, 765-779.
43. Pisani A., Calabresi P., Centonze D., and, Bernardi G., (1997) Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones. Br. J. Pharmacol. 120, 1007-1014.
44. Prybylowski K., Chang K., Sans N., Kan L., Vicini S., and, Wenthold R. J., (2005) The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron 47, 845-857.
45. Rebola N., Lujan R., Cunha R. A., and, Mulle C., (2008) Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron 57, 121-134.
46. Roche K. W., Standley S., McCallum J., Dune Ly C., Ehlers M. D., and, Wenthold R. J., (2001) Molecular determinants of NMDA receptor internalization. Nat. Neurosci. 4, 794-802.
47. Sah P., Hestrin S., and, Nicoll R. A., (1989) Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science 246, 815-818.
48. Sarantis K., Matsokis N., and, Angelatou F., (2009) Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling. Neuroscience 163, 1135-1145.
49. Sarantis K., Antoniou K., Matsokis N., and, Angelatou F., (2012) Exposure to novel environment is characterized by an interaction of D1/NMDA receptors underlined by phosphorylation of the NMDA and AMPA receptor subunits and activation of ERK1/2 signaling, leading to epigenetic changes and gene expression in rat hippocampus. Neurochem. Int. 60, 55-67.
50. Sebastiao A. M., and, Ribeiro J. A., (2000) Fine-tuning neuromodulation by adenosine. Trends Pharmacol. Sci. 21, 341-346.
51. Sheffler D. J., Gregory K. J., Rook J. M., and, Conn P. J., (2011) Allosteric modulation of metabotropic glutamate receptors. Adv. Pharmacol. 62, 37-77.
52. Stelzer A., and, Shi H., (1994) Impairment of GABAA receptor function by N-methyl-D-aspartate-mediated calcium influx in isolated CA1 pyramidal cells. Neuroscience 62, 813-828.
53. Swearengen E., and, Chavkin C., (1987) NMDA receptor antagonist D-APV depresses excitatory activity produced by normorphine in rat hippocampal slices. Neurosci. Lett. 78, 80-84.
54. Takagi N., Besshoh S., Marunouchi T., Takeo S., and, Tanonaka K., (2012) Metabotropic glutamate receptor 5 activation enhances tyrosine phosphorylation of the N-methyl-D-aspartate (NMDA) receptor and NMDA-induced cell death in hippocampal cultured neurons. Biol. Pharm. Bull. 35, 2224-2229.
55. Takasu M. A., Dalva M. B., Zigmond R. E., and, Greenberg M. E., (2002) Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 295, 491-495.
56. Tebano M. T., Martire A., Rebola N., et al,. (2005) Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects. J. Neurochem. 95, 1188-1200.
57. Tse D., Langston R. F., Kakeyama M., Bethus I., Spooner P. A., Wood E. R., Witter M. P., and, Morris R. G., (2007) Schemas and memory consolidation. Science 316, 76-82.
58. Tu J. C., Xiao B., Naisbitt S., et al,. (1999) Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23, 583-592.
59. Ugolini A., Corsi M., and, Bordi F., (1999) Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons. Neuropharmacology 38, 1569-1576.
60. Wang Y. T., and, Salter M. W., (1994) Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 369, 233-235.
61. Wang Y. T., Yu X. M., and, Salter M. W., (1996) Ca(2+)-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase. Proc. Natl Acad. Sci. USA 93, 1721-1725.
62. Yang L., Cranson D., and, Trinkaus-Randall V., (2004) Cellular injury induces activation of MAPK via P2Y receptors. J. Cell. Biochem. 91, 938-950.